Table II.
Linear regression model for parameters associated with microsatellite distance.
| Parameters | r value | 95% CI | t value | P-value |
|---|---|---|---|---|
| Age (years) | −0.04 | −0.30–0.18 | −0.35 | 0.727 |
| BMI (kg/m2) | −0.12 | −0.32–0.09 | −1.10 | 0.274 |
| AST (IU/l) | −0.14 | −0.07–0.34 | 1.32 | 0.192 |
| ALT (IU/l) | −0.005 | −0.21–0.20 | −0.01 | 0.988 |
| PLT (x104/μl) | −0.17 | −0.04–0.37 | 1.47 | 0.145 |
| TBil (mg/dl) | −0.06 | −0.27–0.14 | −0.56 | 0.579 |
| Alb (g/dl) | −0.06 | −0.26–0.16 | −0.45 | 0.651 |
| PT (%) | −0.04 | −0.30–0.18 | 0.08 | 0.935 |
| AFP (ng/ml) | 0.37 | 0.18–0.54 | 3.37 | 0.0003 |
| PIVKA-II (mAU/ml) | 0.40 | 0.20–0.56 | 4.16 | <0.0001 |
| HbA1c (%) | −0.15 | −0.33–0.08 | −1.47 | 0.145 |
| Diameter of tumor (cm) | 0.44 | −0.26–0.60 | 4.63 | <0.0001 |
| SUVmax | 0.58 | 0.41–0.70 | 6.53 | <0.0001 |
CI, confidence interval; BMI, body mass index; AST, aspartate aminotransferase; ALT, alanine aminotransferase; PLT, platelet count; TBil, total bilirubin; Alb, albumin; PT, prothrombin time; AFP, α-fetoprotein; PIVKA-II, protein induced by vitamin K absence or antagonist-II; HbA1c, hemoglobin A1c; SUVmax, maximal standardized uptake value.